大参林: 大参林医药集团股份有限公司2025年第二次临时股东大会会议材料

Group 1 - The meeting of Dazhenglin Pharmaceutical Group Co., Ltd. is scheduled for September 15, 2025, at 10:30 AM, combining on-site and online voting methods [2][3] - The meeting will take place at the company's headquarters in Guangzhou, China, with attendance from shareholders, directors, supervisors, and senior management [2][3] - The agenda includes the election of monitors, reading of meeting notices, and voting on various proposals, including a profit distribution plan [2][5] Group 2 - The proposed profit distribution plan for the first half of 2025 includes a cash dividend of approximately 384.92 million yuan (after tax), which represents 48.23% of the net profit attributable to shareholders [5][6] - The distribution will be based on the total share capital after accounting for any share buybacks and will maintain the per-share distribution ratio despite changes in total share capital due to convertible bonds [5][6]